The researchers uncovered disease-linked genes that are expressed in certain cells and disease stages and discovered various gene expression modules.
The assay monitors mutations across a patient's genome and matches them to mutations found in a patient's resected tumor and in DNA in the bloodstream.
The ALS Association is committing $3.5 million, including a $1 million commitment from its Greater New York chapter, while the Tow Foundation is contributing $2.5 million.
While the New York Genome Center says whole-genome cancer sequencing is the future, companies already offering such tests are struggling to get paid.
The funding is being provided to a number of early-career investigators and collaborative research groups using genomics and other technologies.
The companies will offer BGI's DNBseq next-generation sequencing technology along with Gencove's ImputeSeq low-pass sequencing analysis pipeline.
In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.
The two papers published today in Science and Cell have implications for both forensics and genetic research.
Initiated the by New York Genome Center Cancer Group, the Polyethnic-1000 project will focus on cancer patients from ethnic minority groups.
A study found that cis-regulatory variation modifies the penetrance of coding variants, and that variants' regulatory haplotype configuration affects disease risk.
The long-running Framingham Heart Study has received a $38 million grant, according to the Boston Globe.
A Stanford University investigation finds that its researchers did not take part in He Jiankui's work to develop gene-edited infants.
Retraction Watch reports that two researchers had both a Science and a Nature paper retracted last week.
In Genome Biology this week: genomic sequencing of milkweed bug, benchmark comparison of single-cell RNA sequencing platforms, and more.